Literature DB >> 2406867

Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis.

A A Lindberg1, A Weintraub, U Zähringer, E T Rietschel.   

Abstract

The endotoxic activity of lipopolysaccharide (LPS) extracted from the envelope of Bacteroides fragilis is low compared with that of LPS from Escherichia coli, Salmonella, and other Enterobacteriaceae. Thus, pyrogenicity, the ability to prepare for or provoke the local Shwartzman reaction, and the ability to induce the production of interleukin 1 are reduced by 100- to 1,000-fold. Structural analyses of characterized B. fragilis LPS have shown that its lipid A is composed of a beta 1,6-linked D-glucosamine disaccharide that has the following properties: (1) a phosphate group on C1 of the reducing amino sugar, (2) amide- and ester-linked 3-hydroxylated branched and nonbranched long-chain (C15-C17) fatty acids, (3) an average of five fatty acids per glucosamine disaccharide, and (4) the core and O-antigenic saccharide chain linked to C6 of the nonreducing glucosamine residue. Although structurally similar to lipid A of E. coli, the lipid A of B. fragilis differs by its lack of the phosphate group on C4 of the nonreducing amino sugar and by the presence of fewer and different fatty acids. These differences explain the low endotoxic activity of B. fragilis LPS. The core and O-antigenic chain are linked to lipid A via a phosphorylated 2-keto-3-deoxyoctonate (KDO) residue. The saccharide chain is short and is composed of L-rhamnose, D-glucose, and D-galactose, with the O-antigenic specificity determined by a beta 1,6-linked D-galactose oligomer. This O-antigenic specificity was present in 14 of 17 strains of B. fragilis that were investigated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406867     DOI: 10.1093/clinids/12.supplement_2.s133

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  34 in total

1.  Monocytic cell activation by Nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2.

Authors:  S Sugawara; S Yang; K Iki; J Hatakeyama; R Tamai; O Takeuchi; S Akashi; T Espevik; S Akira; H Takada
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Authors:  Robert S Munford; Jerrold P Weiss; Mingfang Lu
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

3.  Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.

Authors:  A Pantosti; A O Tzianabos; A B Onderdonk; D L Kasper
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 4.  Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.

Authors:  Connie W Y Ha; Yan Y Lam; Andrew J Holmes
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  Biochemical Transformation of Bacterial Lipopolysaccharide by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Authors:  Robert S Munford; Jerrold P Weiss; Mingfang Lu
Journal:  J Biol Chem       Date:  2020-10-26       Impact factor: 5.157

6.  Commensal Microbiota Modulation of Natural Resistance to Virus Infection.

Authors:  Kailyn L Stefan; Myoungjoo V Kim; Akiko Iwasaki; Dennis L Kasper
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

7.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 8.  Models matter: the search for an effective Staphylococcus aureus vaccine.

Authors:  Wilmara Salgado-Pabón; Patrick M Schlievert
Journal:  Nat Rev Microbiol       Date:  2014-07-07       Impact factor: 60.633

9.  Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development.

Authors:  Mizuho Hasegawa; Toshifumi Osaka; Kazuki Tawaratsumida; Takashi Yamazaki; Hiroyuki Tada; Grace Y Chen; Satoshi Tsuneda; Gabriel Núñez; Naohiro Inohara
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

10.  Splenic B-cell activation in lipopolysaccharide-non-responsive C3H/HeJ mice by lipopolysaccharide of Porphyromonas gingivalis.

Authors:  H Shimauchi; T Ogawa; H Uchida; J Yoshida; H Ogoh; T Nozaki; H Okada
Journal:  Experientia       Date:  1996-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.